Recent QNRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 08:30:08 PM
- Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO • GlobeNewswire Inc. • 09/09/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:06:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:03:37 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/12/2024 08:32:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:01:28 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome • GlobeNewswire Inc. • 08/06/2024 09:00:00 AM
- Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • GlobeNewswire Inc. • 08/01/2024 08:10:00 PM
- Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference • GlobeNewswire Inc. • 06/25/2024 08:05:00 PM
- Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland • GlobeNewswire Inc. • 06/12/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:10:54 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/08/2024 08:00:53 PM
- Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 08:10:00 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results • GlobeNewswire Inc. • 03/13/2024 08:05:00 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 09:06:10 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 09:04:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:01:51 PM
- Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/06/2024 10:07:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:01:40 PM
- Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM